Harm reduction, public health, and human rights: Smokers have a right to be informed of significant harm reduction options

Nicotine and Tobacco Research

Volumn 4, Issue SUPPL. 2, 2002, Pages

  Kozlowski, Lynn T ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; TAR;

CIGARETTE SMOKING; EVIDENCE BASED MEDICINE; HAZARD ASSESSMENT; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH HAZARD; HUMAN; HUMAN RIGHTS; MEDICAL INFORMATION; MORTALITY; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SMOKELESS TOBACCO;

EID: 0036958834     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/1462220021000032843     Document Type: Review

References (45)

1. Annas, G. J. (1999). The impact of health policies on human rights: AIDS and TB control. In J. Mann, S. Gruskin, M. Grodin, & G. Annas (Eds.), Health and Human Rights. New York: Routledge Publishing.
2. Beauchamp, T. L., Childress, J. F. (1994). Principles of Biomedical Ethics (4th ed.). New York: Oxford University Press.
3. Benowitz, N. L. (Ed.). (1998). Nicotine safety and toxicity. New York: Oxford Press.
4. Benowitz, N. L., & Gourlay, S. G. (1997). Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. Journal of the American College of Cardiology, 29, 1422-1431.
5. Benowitz, N. L., Hall, S. M., Herning, R. I., Jacob, P. III, Jones, R.. T., & Osman, A.-L. (1983). Smokers of low-yield cigarettes do not consume less nicotine. New England Journal of Medicine, 309, 134-142.
6. Bird, M. E. (2001, May). Human rights and health. The Nation's Health, 3.
7. Burns, D., Major, J., Shanks, T., & Thun, M.. (2001). Smoking lower yield cigarettes and disease risk. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and Tobacco Control Monograph No. 13. (NIH Publication No. 02-5074). Retrieved July 10, 2002, from http://cancercontrol.cancer.gov/tcrb/monographs/13/
8. Cohen, S. I. (1994). Developing information, education, and communications (IEC) strategies for population programmes. Technical Paper No.1. New York: United National Population Fund (UNPFA).
9. Corrao, M. A., Guindon, G. E., Sharma, N., & Shokoohi, D. F. (Eds.). (2000). Tobacco Control Country Profiles. Atlanta, GA: American Cancer Society.
10. English, D. R., Holman, C. D. J., Milne, E., Winter, M. G., Hulse, G. K., Codde, J. P., Bower, C. I., Corti, B., de Klerk, N., Knuiman, M. W, Kurinczuk, J. J., Lewin, G. F., & Ryan, G. A. (1995). The quantification of drug caused morbidity and mortality in Australia, 1995 Edition. Canberra: Commonwealth Department of Human Services and Health.
11. Ferrence, R., Slade, J., Room, R., & Pope, M. (Eds.). (2000). Nicotine and Public Health. Washington, DC: American Public Health Association.
12. Freedman, L. P. (1995). Censorship and manipulation of family planning information: an issue of human rights and women's health. In S. Coliver (Ed.) The right to know: Human rights and access to reproductive health information. Philadelphia: University of Pennsylvania Press.
13. Freedman, L. P. (1999). Reflections on emerging frameworks of health and human rights. In J. Mann, S. Gruskin, M. Grodin, & G. Annas (Eds.), Health and Human Rights. New York: Routledge Publishing.
14. Gostin, L., & Mann, J. (1999). Toward the development of a human rights impact assessment for the formulation and evaluation of public health policies. In J. Mann, S. Gruskin, M. Grodin, & G. Annas (Eds.), Health and Human Rights. New York: Routledge Publishing.
15. Greenland, S., Satterfield, M. H., & Lanes, S. F. (1998). A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Safety, 18, 297-308.
16. Henningfield, J. E., & Fagerström, K. O. (2001). Swedish Match Company, Swedish snus and public health: A harm reduction experiment in progress? Tobacco Control, 10, 253-257.
17. Henningfield, J. E., & Fant, R. V. (2000). Nicotine delivery systems: Implications for Abuse Potential, Medications Development, and Public Health. In R. Ferrence, J. Slade, R. Room, & M. Pope (Eds.), Nicotine and Public Health (pp. 229-247). Washington, DC: American Public Health Association.
18. Hughes, J. R. (1998). Dependence on and abuse of nicotine replacement medications: an update. In N. L. Benowitz (Ed.), Nicotine safety and toxicity (pp. 147-157). New York: Oxford Press.
19. International Federation of Red Cross and Red Crescent Societies & François-Xavier Bagnoud Center for Health and Human Rights. 1999. In J. Mann, S. Gruskin, M. Grodin, & G. Annas (Eds.), Health and Human Rights. New York: Routledge Publishing.
20. Jarvis, M. J., Boreham, R., Primatesta, P., Feyerabend, C., & Bryant, A. (2001). Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: Evidence from a representative population survey. Journal of the National Cancer Institute, 93, 134-138.
21. Kimmel, S. E., Berlin, J. A., Miles, C., Jaskowiak, J., Carson, J. L., & Strom, B. L. (2001). Risk of acute first myocardial infarction and use of nicotine patches in a general population. Journal of the American College of Cardiology, 37, 1297-1302.
22. Kozlowski, L. T., & Sweeney, C. T. (1997). Low-yield, light, and ultra-light cigarettes: let's understand the product before we promote. In M. E. Goldberg, M. Fishbein, & S. Middlestadt (Eds.), Social marketing: Theoretical and practical perspectives. Mahwah, New Jersey: Erlbaum.
23. Kozlowski, L. T., O'Connor, R. J. (2000). Official cigarette tar tests are misleading: Use a two-stage, compensating test. Lancet, 355, 2159-2161.
24. Kozlowski, L. T., & O'Connor, R. J. (2002). Filter ventilation is a defective design because of misleading taste, bigger puffs, blocked vents. Tobacco Control (Suppl. 1), i40-i50,
25. Kozlowski, L. T., Strasser, A. A., Giovino, G. A., Erickson, P. A., & Terza, J. V. (2001). Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction. Tobacco Control, 10, 201-203.
26. Lewin, F., Novell, S. E., Johansson, H., Gustavsson, P., Wennerberg, J., Biorklund, A., & Rutqvist, L. E. (1998). Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer, 82, 1367-1375.
27. Mann, J. M. (1999). Medicine and public health, ethics and human rights. In J. Mann, S. Gruskin, M. Grodin, & G. Annas (Eds.), Health and Human Rights (pp. 439-452). New York: Routledge Publishing.
28. Mann, J. M., Gostin, L., Gruskin, S., Brennan, T., Lazzarini, Z., & Fineberg, H. (1999). Health and human rights. In J. Mann, S. Gruskin, M. Grodin, & G. Annas (Eds.), Health and Human Rights (pp. 7-20). New York: Routledge Publishing.
29. McCullough L., & Wear, S. (1985). Respect for automony and medical paternalism reconsidered. Theoretical Medicine, 6, 295-308.
30. Murray, R. P., & Daniels, K. (1998). Long-term nicotine therapy. In N. L. Benowitz (Ed.), Nicotine safety and toxicity (pp. 173-182). New York: Oxford Press.
31. National Cancer Institute. (1996). The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of U.S. Cigarettes: Smoking and Tobacco Control Monograph 7. Bethesda, MD: National Cancer Institute.
32. Nuremberg code: Directives for human experimentation. 1949. Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10, Vol. 2 (pp. 181-182). Washington, DC: U.S. Government Printing Office.
33. Pauly, J. L., Streck, R. J., & Cummings, K. M. (1995). US patents shed light on Eclipse and future cigarettes. Tobacco Control, 4, 261-265.
34. Peto, R., Lopez, A. D., Boreham, J., Thun, M., & Heath, C. (1994). Mortality from smoking in developed countries 1950-2000. Oxford, England: Oxford University Press.
35. Pierce J. (2000). Discussant remarks. In R. Ferrence, J. Slade, R. Room, & M. Pope (Eds.), Nicotine and public health (p. 227). Washington, DC: American Public Health Association.
36. Ramström, L. M. (2000). Snuff - An alternative nicotine delivery system. In R. Ferrence, J. Slade, R. Room, & M. Pope (Eds.), Nicotine and public health (pp. 159-174). Washington, DC: American Public Health Association.
37. Rennard, S. I., Daughton, D., & Windle, J. (1998). Toxicity of nicotine replacement in patients with coronary artery disease. In N. L. Benowitz (Ed.), Nicotine safety and toxicity (pp. 49-53). New York: Oxford Press.
38. Reuter, P. (2000). Discussant remarks. In R. Ferrence, J. Slade, R. Room, & M. Pope (Eds.), Nicotine and public health (p. 337). Washington, DC: American Public Health Association.
39. Rodu, B., Cole, P. (1994). Tobacco-related mortality. Nature, 370, 184.
40. Rodu, B., Cole, P. (1999). Nicotine maintenance for inveterate smokers. Technology, 6, 17-21.
41. Russell, M. A. H., Jarvis, M. J., & Feyerabend, C. (1980). A new age for snuff? Lancet, 1, 474-475.
42. Stratton, K., Shetty, P., Wallace, R., & Bondurant, S. (Eds.). (2001). Clearing the smoke: Assessing the science base for tobacco harm reduction. Washington, DC: National Academy Press.
43. U. S. Department of Health and Human Services. (1989). Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. (DHHS Publication No. CDC 89-8411. Washington: U.S. Government Printing Office. Retrieved July 10, 2002, from http://www.cdc.gov/tobacco/sgr_1988.htm
44. Universal Declaration of Human Rights. (1948). Cited in J. Mann, S. Gruskin, M. Grodin, & G. Annas (Eds.), Health and Human Rights. New York: Routledge Publishing.
45. Wear, S. (1998). Informed consent: Patient autonomy and clinician beneficence within health care (2nd ed.). Washington, DC: George-town University Press.